Asia Pacific Chronic Cough Market Developments and Forecast by 2027
Asia Pacific Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class, Route of Administration, Distribution Channel, and Country
- Status : Published
- Report Code : TIPRE00013263
- Category : Life Sciences
- No. of Pages : 153
- Available Report Formats :
- Last update date : January 22, 2021
2019 Market Size
US$ 1,136.66 Mn
Base year value
2027 Forecast
US$ 2,155.25 Mn
Projected by 2027
CAGR 2020-2027
8.4 %
Growth rate
Addressable Market
US$ 13,296.67 Mn
(2020-2027)
The chronic cough market in Asia Pacific is expected to grow from US$ 1,136.66 million in 2019 to US$ 2,155.25 million by 2027. This represents a CAGR of 8.4% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to rising incidences of chronic cough, growing product developments to treat chronic cough. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the Asia Pacific chronic cough market during the forecast period. The India has observed fast growth in the chronic cough market within the past few years and is expected to lead the market in Asia Pacific during the forecast period.Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. Developing countries have to bear the burden of both communicable and noncommunicable diseases simultaneously. The recent Global Burden of Disease (GBD) survey data have shown that both acute and chronic respiratory diseases are prevalent in substantial number in India. Chronic respiratory diseases, especially asthma and chronic obstructive pulmonary disease (COPD), are of particular importance for having wide variations in morbidity and mortality in various Indian states. There were 28.1 million cases of COPD in India in 1990; this increased to 55.3 million in 2016, showed a September 2018 study published in The Lancet Global Health. India has 18% of the world’s population but 32% of its COPD burden; it further showed Chronic Obstructive Pulmonary Disease (COPD) was the second-highest cause of death in India after heart disease in 2017, killing 1 million (958,000) Indians that year, according to University of Washington’s Global Burden of Disease study, 2018.
India Chronic Cough Market Revenue and Forecast to 2027 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
ASIA PACIFICCHRONIC COUGH – MARKET SEGMENTATION
By Drug Class
- Antihistamines
- Corticosteroids
- Decongestants
- Combination Drug
- Antibiotics
- Acid Blockers
- Other Drug Class
By Route of Administration
- Oral
- Injections
- Nasal
- Other Route of Administration
By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
By Country
- Japan
- China
- India
- South Korea
- Australia
Company Profiles
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- Bayer AG
- Mylan N.V.
- Amneal Pharmaceuticals, Inc.
- Cipla Inc.
- Reckitt Benckiser Group plc.
- Sun Pharmaceutical Industries Ltd
- Aurobindo Pharma Ltd
Asia Pacific Chronic Cough Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,136.66 Million |
| Market Size by 2027 | US$ 2,155.25 Million |
| CAGR (2020 - 2027) | 8.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Drug Class
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners provided valuable market intelligence that supported our global go-to-market strategy. Their team was professional, responsive, and attentive to our feedback, providing thoughtful analysis and helpful methodological clarifications throughout the project.
Junmo Kim Chief Financial Officer (CFO), Enertech Co., Ltd.
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for